Temat: "Amyloidosis" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review.
Autorzy:: Berends M; Department of Internal Medicine, Amyloidosis Center of Expertise, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Nienhuis HLA; Department of Internal Medicine, Amyloidosis Center of Expertise, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Adams D; Service de Neurologie, CHU Bicêtre, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, CERAMIC, Le Kremlin-Bicêtre, 94270 Paris, France.
Karam C; Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Luigetti M; UOC Neurologia, Fondazione Policlinico A. Gemelli IRCCS, 00168 Rome, Italy.; Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Polydefkis M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Reilly MM; Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Sekijima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Hazenberg BPC; Department of Rheumatology & Clinical Immunology, Amyloidosis Center of Expertise, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 28; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Immunoglobulin Light-chain Amyloidosis*
Amyloidosis*
Polyneuropathies*
Humans ; Prealbumin/genetics ; Intermediate Filaments ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Needs of amyloidosis patients and their care providers: design & first results of the A MY-NEED S research and care program.
Autorzy:: Ihne-Schubert SM; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany. ihne_.; Department of Internal Medicine II, Hematology, University Hospital of Würzburg, Würzburg, Germany. ihne_.; Department of Internal Medicine IV, University Hospital of Gießen and Marburg, Gießen, Germany. ihne_.; Centre for Innovation Research, Lund University, Lund, Sweden. ihne_.
Radovic T; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.
Fries S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.
Frantz S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center (CHFC), University and University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine I, Cardiology, University Hospital of Würzburg, Würzburg, Germany.
Einsele H; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine II, Hematology, University Hospital of Würzburg, Würzburg, Germany.
Störk S; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center (CHFC), University and University Hospital of Würzburg, Würzburg, Germany.; Department of Internal Medicine I, Cardiology, University Hospital of Würzburg, Würzburg, Germany.
Neuderth S; Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany.; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 10; Vol. 19 (1), pp. 58. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Caregivers*/psychology
Amyloidosis*
Humans ; Health Personnel ; Focus Groups

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
Autorzy:: Kennel SJ; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Jackson JW; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Stuckey A; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Richey T; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Foster JS; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.
Wall JS; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0301756. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Amyloidosis*/diagnostic imaging
Amyloidosis*/metabolism
Cardiomyopathies*/diagnostic imaging
Humans ; Mice ; Animals ; Positron Emission Tomography Computed Tomography ; Tomography, Emission-Computed, Single-Photon/methods ; Peptides ; Amyloid/metabolism ; Prealbumin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
Autorzy:: Maury P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.; I2MC, INSERM UMR 1297, Toulouse, France.
Sanchis K; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Djouadi K; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.
Cariou E; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Delasnerie H; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Boveda S; Clinique Pasteur, Toulouse, France.
Fournier P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Itier R; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Mondoly P; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Voglimacci-Stephanopoli Q; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Beneyto M; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Dhanjal TS; Department of Cardiology, University of Warwick, Coventry, United Kingdom.
Rollin A; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Damy T; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.
Lairez O; Department of Cardiology, University Hospital Toulouse, Toulouse, France.
Lellouche N; Department of Cardiology, University Hospital Henri Mondor, Creteil, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 05; Vol. 19 (4), pp. e0301753. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/complications
Atrial Fibrillation*/surgery
Tachycardia, Supraventricular*
Heart Failure*/complications
Heart Failure*/surgery
Amyloidosis*/complications
Amyloidosis*/surgery
Catheter Ablation*/adverse effects
Humans ; Retrospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Lymphocytic Myocarditis with Increased Left Ventricular Thickness: A Rare Presentation Mimicking Cardiac Amyloidosis.
Autorzy:: Duan X; Department of Cardiovascular Medicine, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Jinhua, Zhejiang, China (mainland).
Qu L; Department of Cardiovascular Medicine, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Jinhua, Zhejiang, China (mainland).
Chen H; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University School, Hangzhou, Zhejiang, China (mainland).; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Mar 25; Vol. 25, pp. e942760. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Myocarditis*/diagnosis
Amyloidosis*/diagnosis
Atrial Fibrillation*
Male ; Humans ; Aged, 80 and over ; Myocardium/pathology ; Echocardiography

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer's disease.
Autorzy:: Van Hoecke L; VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, 9000, Belgium.
Vandenbroucke RE; VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, Ghent, 9052, Belgium. .; Department of Biomedical Molecular Biology, Ghent University, Ghent, 9000, Belgium. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 18; Vol. 12 (1), pp. 41. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Letter
MeSH Terms:: Alzheimer Disease*/genetics
Amyloidosis*/genetics
Mice ; Animals ; Amyloid beta-Peptides/genetics ; Disease Models, Animal

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Proximity-Induced Pharmacology for Amyloid-Related Diseases.
Autorzy:: Bertran-Mostazo A; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
Putriūtė G; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.
Álvarez-Berbel I; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.
Busquets MA; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Galdeano C; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
Espargaró A; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Sabate R; Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.; Pokaż więcej
Źródło:: Cells [Cells] 2024 Mar 04; Vol. 13 (5). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Alzheimer Disease*/metabolism
Amyloidosis*
Humans ; Amyloid beta-Peptides/metabolism ; Plaque, Amyloid/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Autorzy:: Bosch ME; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Dodiya HB; Department of Neurobiology, University of Chicago, Chicago, USA.
Michalkiewicz J; Department of Neurobiology, University of Chicago, Chicago, USA.
Lee C; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Shaik SM; Department of Neurobiology, University of Chicago, Chicago, USA.
Weigle IQ; Department of Neurobiology, University of Chicago, Chicago, USA.
Zhang C; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Osborn J; Department of Neurobiology, University of Chicago, Chicago, USA.
Nambiar A; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Patel P; Center for Genetic Medicine, Northwestern University, Chicago, USA.
Parhizkar S; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA.
Zhang X; Department of Neurobiology, University of Chicago, Chicago, USA.
Laury ML; Genome Technology Access Center, Washington University in St. Louis, St. Louis, USA.
Mondal P; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Gomm A; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Schipma MJ; Center for Genetic Medicine, Northwestern University, Chicago, USA.
Mallah D; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Butovsky O; Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Chang EB; Department Medicine, Section of Gastroenterology, Hepatology, and Nutrition, The University of Chicago, Chicago, USA.
Tanzi RE; Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Gilbert JA; Department of Pediatrics and Scripps Institution of Oceanography, UCSD, San Diego, USA.
Holtzman DM; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, USA. .
Sisodia SS; Department of Neurobiology, University of Chicago, Chicago, USA. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2024 Feb 17; Vol. 19 (1), pp. 18. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/metabolism
Gastrointestinal Microbiome*
Amyloidosis*/metabolism
Humans ; Mice ; Male ; Female ; Animals ; Microglia/metabolism ; Mice, Transgenic ; Amyloid beta-Peptides/metabolism ; Plaque, Amyloid/pathology ; Amyloid/metabolism ; Amyloidogenic Proteins/metabolism ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.
Autorzy:: Zuppo Laper I; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Camacho-Hubner C; Pfizer Global, New York City, New York, United States of America.
Vansan Ferreira R; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Leite Bertoli de Souza C; Pfizer Brazil, São Paulo, São Paulo, Brazil.
Simões MV; Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Fernandes F; Heart Institute, University of São Paulo, São Paulo, Brazil.
de Barros Correia E; Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.
de Jesus Lopes de Abreu A; IQVIA Brazil, São Paulo, São Paulo, Brazil.
Silva Julian G; Pfizer Brazil, São Paulo, São Paulo, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0278738. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Amyloidosis*
Cardiomyopathies*/diagnosis
Cardiomyopathies*/epidemiology
Amyloid Neuropathies, Familial*/diagnosis
Amyloid Neuropathies, Familial*/epidemiology
Humans ; Brazil/epidemiology ; Prealbumin ; Public Health ; Retrospective Studies ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in AppNL-G-F Alzheimer's disease model mice.
Autorzy:: Bellio TA; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Laguna-Torres JY; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Campion MS; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Chou J; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Yee S; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Blusztajn JK; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.
Mellott TJ; Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 05; Vol. 19 (2), pp. e0297289. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/drug therapy
Alzheimer Disease*/prevention & control
Alzheimer Disease*/pathology
Amyloidosis*/pathology
Pregnancy ; Female ; Mice ; Animals ; Mice, Transgenic ; Lactation ; Disease Models, Animal ; Brain/metabolism ; Choline/pharmacology ; Memory Disorders/drug therapy ; Memory Disorders/prevention & control ; Memory Disorders/pathology ; Maze Learning ; Dietary Supplements ; Amyloid beta-Peptides/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Amyloidosis"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji

Starter badań:

Amyloidosis.